On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
pembrolizumab
.
Show all posts
Showing posts with label
pembrolizumab
.
Show all posts
Sunday, January 04, 2026
Excessive number of clinical trial protocol amendments due to complex trial design
›
In a previous blog post "Protocol amendment in clinical trials", I discussed the impact of protocol amendments on the clinical tri...
2 comments:
›
Home
View web version
